Drug Shortage Report for SANDOSTATIN

Last updated on 2023-01-25 History
Report ID 160174
Drug Identification Number 00839205
Brand name SANDOSTATIN
Common or Proper name SANDOSTATIN 100UG 1ML 1X5
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) OCTREOTIDE
Strength(s) 100MCG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS
Packaging size 1mL
ATC code H01CB
ATC description HYPOTHALAMIC HORMONES
Reason for shortage Demand increase for the drug.
Anticipated start date 2022-05-10
Actual start date 2022-07-29
Estimated end date 2023-01-30
Actual end date
Shortage status Actual shortage
Updated date 2023-01-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2023-01-25 French Compare
v12 2023-01-25 English Compare
v11 2022-11-22 French Compare
v10 2022-11-22 English Compare
v9 2022-09-29 French Compare
v8 2022-09-29 English Compare
v7 2022-07-29 French Compare
v6 2022-07-29 English Compare
v5 2022-07-14 French Compare
v4 2022-07-14 English Compare
v3 2022-05-11 English Compare
v2 2022-05-06 French Compare
v1 2022-05-06 English Compare

Showing 1 to 13 of 13